Great news and new hope!
CIC and the UMMC Covid-19 special taskforce go full force looking for new treatment for Covid-19 patients.
“UMMC has already used tocilizumab (trade name Actemra) on several Covid-19 patients who developed “cytokine storm” syndrome, a dangerous overreaction of the immune system, resulting in respiratory and multi-organ failure and said that the results were encouraging”.
We are proud to announce a remarkable milestone for Universiti Malaya Medical Centre (UMMC) in the ZENITH High Proteinuria (D4325C00010) study. Under the leadership of
We are thrilled to announce that Universiti Malaya Medical Centre (UMMC), under the leadership of Assoc. Prof. Dr. Rozita Binti Abdul Malik, has been recognized
This morning, the Clinical Investigation Centre (CIC) at Universiti Malaya Medical Centre (UMMC) hosted the MSD and UMMC Clinical Trial Partnership Meeting, a significant step
We are proud to celebrate the exceptional achievements of Assoc. Prof. Dr. Adlinda Alip and her dedicated team at Universiti Malaya Medical Centre (UMMC) in
© CIC. All Rights Reserved. 2024